Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Prostate cancer
Country:  U.S.A.
Trial Type:  Prevention
Trial Status:  Active
Results 1-6 of 6 for your search:
Start Over
3 Month Finasteride Challenge Test Can Significantly Improve the Performance of Screening for Prostate Cancer
Phase: Phase IV
Type: Prevention
Status: Active
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: ROI10-352, R01CA138627, NCT01296672
Exercise Intervention Metabolic Syndrome Prostate Cancer Black Men
Phase: Phase II, Phase I
Type: Prevention
Status: Active
Age: 40 to 70
Sponsor: Other
Protocol IDs: Georgetown_University_MC1, NCT02379559
Pomegranate-Extract Pill in Preventing Tumor Growth in Patients With Localized Prostate Cancer Undergoing Active Surveillance
Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: NCI-2014-00695, N01-CN-2012-00033, CO11378, UWI2013-00-01, N01CN00033, N01CN35153, P30CA014520, NCT02095145
Effect of Quercetin on Green Tea Polyphenol Uptake in Prostate Tissue From Patients With Prostate Cancer Undergoing Surgery
Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 40 to 75
Sponsor: NCI, Other
Protocol IDs: 12-000886, NCI-2013-01153, P30CA016042, R03CA171583, NCT01912820
Effect of Lap-Band Induced Weight Loss on Serum PSA Levels
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 20 to 60
Sponsor: Other
Protocol IDs: 07/09/VA18, NCT00562341
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Prevention
Status: Active
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: Portland VA-09-0607, 2096, 6232, 2PO1CA090890-06A2, NCT01265953
Start Over